Literature DB >> 8557435

The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.

T E Taha1, G A Dallabetta, J K Canner, J D Chiphangwi, G Liomba, D R Hoover, P G Miotti.   

Abstract

BACKGROUND: Low birthweight, prematurity and intra-uterine growth retardation (IUGR) are major determinants of child survival. Therefore, it is important to assess excess mortality due to human immunodeficiency virus (HIV) infection in populations where low birthweight is common.
METHODS: A prospective study was conducted on 1385 children born to seropositive and seronegative women in urban Malawi. Children were regularly examined and tested for HIV.
RESULTS: The mortality rate of children of HIV seropositive mothers was substantially higher (223/1000 at 12 months, 317/1000 at 24 months and 360/1000 at 30 months) than that of children of seronegative mothers (68/1000 at 12 months, 106/1000 at 24 months and 118/1000 at 30 months). The incidence of prematurity and IUGR was also higher in infants of HIV seropositive mothers than in infants of seronegative mothers (12.7% versus 3.8%, P < 0.001 for premature and 7.7% versus 4.4%, P = 0.02 for IUGR infants). The mother-to-infant HIV-1 transmission rate was 35.1%. After 12 months of age, HIV infected children showed the highest mortality; however, uninfected children of HIV seropositive and children of HIV seronegative mothers had similar mortality. The mean birthweight of HIV infected and uninfected children was not significantly different. In HIV infected children the most frequent causes of death were diarrhoea, pneumonia and failure to thrive. Less common risk factors for child mortality included active maternal syphilis and cervicitis/vaginitis.
CONCLUSION: The substantial difference in survival among children of HIV infected and uninfected mothers suggests that mortality could be reduced if HIV infection were not a risk factor. To decrease childhood mortality, a combination of interventions such as treatment of sexually transmitted infections during pregnancy and measures to reduce mother-to-infant transmission should be adopted.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Birth Weight; Body Weight; Child Mortality; Correlation Studies; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Infant Mortality; Low Birth Weight; Malawi; Mortality; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Outcomes; Premature Birth; Reproduction; Research Methodology; Statistical Studies; Studies; Vertical Transmission; Viral Diseases

Mesh:

Year:  1995        PMID: 8557435     DOI: 10.1093/ije/24.5.1022

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  29 in total

1.  Timing of growth faltering in rural Malawi.

Authors:  K Maleta; S Virtanen; M Espo; T Kulmala; P Ashorn
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

Authors:  Bill G Kapogiannis; Minn M Soe; Steven R Nesheim; Elaine J Abrams; Rosalind J Carter; John Farley; Paul Palumbo; Linda J Koenig; Marc Bulterys
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

3.  Adverse birth outcomes in a malarious area.

Authors:  B F Kalanda; F H Verhoeff; L Chimsuku; G Harper; B J Brabin
Journal:  Epidemiol Infect       Date:  2005-10-28       Impact factor: 2.451

4.  Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants.

Authors:  Emily L Deichsel; Patricia B Pavlinac; Barbra A Richardson; Dorothy Mbori-Ngacha; Judd L Walson; Christine J McGrath; Carey Farquhar; Rose Bosire; Elizabeth Maleche-Obimbo; Grace C John-Stewart
Journal:  Matern Child Nutr       Date:  2019-08-06       Impact factor: 3.092

5.  Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.

Authors:  D A Dibbern; G W Glazner; I Gozes; D E Brenneman; J M Hill
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 6.  Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Authors:  Roy J Kim; Richard M Rutstein
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

7.  Fetal immune activation to malaria antigens enhances susceptibility to in vitro HIV infection in cord blood mononuclear cells.

Authors:  Kevin Steiner; Latoya Myrie; Indu Malhotra; Peter Mungai; Eric Muchiri; Arlene Dent; Christopher L King
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

8.  Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).

Authors:  Sufia Dadabhai; Luis Gadama; Rachel Chamanga; Rachel Kawalazira; Chaplain Katumbi; Bonus Makanani; Dingase Dula; Nan Hua; Bryan Lau; Macpherson Mallewa; Taha E Taha
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

9.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

10.  Challenges in infant and young child nutrition in the context of HIV.

Authors:  Tin Tin Sint; Ronnie Lovich; Wendy Hammond; Maria Kim; Sara Melillo; Lydia Lu; Pamela Ching; Jennifer Marcy; Nigel Rollins; Emilia H Koumans; Amie N Heap; Margaret Brewinski-Isaacs
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.